As hepatocellular carcinoma progresses, T-lymphocytes, natural killer cells, B lymphocytes, Mφ and GrB-expressing cells decrease. This indicates that these cells may be important markers of prognosis.

In our small study, patients with carotid artery stent placement who received dual antiplatelet therapy had a significant reduction in gastrointestinal bleeding with omeprazole use when compared to those without omeprazole. There was also no effect of concomitant use of omeprazole and clopidogrel on antiplatelet inhibition.